Skip to main content

UPDATE 2-Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch

* Teva shares jump 8.5 percent in early U.S. trading (Adds CEO comments from conference call, share reaction)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.